Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All" or closing out of this banner, you accept our Privacy Policy and Terms of Service, revised from time to time, and you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties. You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
saas: Archive
Intuit Gears Up to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Intuit's second-quarter fiscal 2025 results might benefit from strength in Online Ecosystem business. Desktop changes and Mailchimp headwinds may put pressure on results.
INTUNegative Net Change MRVLNegative Net Change VYXNegative Net Change ASNegative Net Change
saas tech-stocks
Should You Buy 89BIO (ETNB) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
ETNBPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Precigen, Inc. (PGEN) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
PGENNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Lionsgate Studios Corp. (LION)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
LIONNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Palo Alto Networks Soars 13% YTD: Time to Buy, Hold or Sell the Stock?
by Anirudha Bhagat
Despite near-term challenges, PANW is worth holding due to its leadership in cybersecurity, AI-driven innovation and strategic shift toward a platform-based model.
FTNTNegative Net Change PANWNegative Net Change CYBRNegative Net Change CRWDNegative Net Change
artificial-intelligence computers cybersecurity internet saas software tech-stocks
Cloudflare Soars 49% YTD: Should You Hold or Fold the Stock?
by Anirudha Bhagat
While NET is poised to benefit from continued strength in AI, security and cloud networking, the stock's high valuation warrants a cautious approach.
FIVNPositive Net Change TEAMNegative Net Change TWLONegative Net Change NETNegative Net Change
artificial-intelligence computers cybersecurity internet saas tech-stocks
Should You Buy Portillo's Inc. (PTLO) After Golden Cross?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
PTLONegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Twilio Stock Falls 7% on Q4 Earnings Miss and Dull Q1 EPS Guidance
by Zacks Equity Research
TWLO's fourth-quarter 2024 results reflect the benefit of growth in communications revenues and improved cost discipline.
PLNegative Net Change FTNTNegative Net Change TEAMNegative Net Change TWLONegative Net Change
artificial-intelligence computers earnings internet saas tech-stocks
Toast to Report Q4 Earnings: What's in Store for the Stock?
by Zacks Equity Research
TOST's fourth-quarter 2024 results are likely to gain from location additions and international expansion, offset by rising expenses and economic headwinds.
ACNNegative Net Change AKAMNegative Net Change ATHMNegative Net Change TOSTNegative Net Change
saas tech-stocks
Paycom Software Q4 Earnings and Revenues Top Estimates, Rise Y/Y
by Zacks Equity Research
PAYC's fourth-quarter performance benefited from increased sales momentum, international expansion and artificial intelligence integration in its products.
PLNegative Net Change FTNTNegative Net Change PAYCNegative Net Change TEAMNegative Net Change
artificial-intelligence computers earnings saas tech-stocks
Is FTNT Stock a Buy on Q4 Earnings Beat & Rising EPS Estimates?
by Vasundhara Sawalka
Fortinet beats Q4 estimates with 45.1% EPS growth. Strong margins, SASE expansion and AI security drive a positive 2025 outlook.
CSCONegative Net Change CHKPNegative Net Change FTNTNegative Net Change PANWNegative Net Change
saas tech-stocks
Yelp Gears Up to Report Q4 Earnings: Is a Beat in the Cards?
by Zacks Equity Research
YELP's fourth-quarter 2024 results are likely to reflect benefits from increasing advertising revenues and its AI and machine learning efforts.
AKAMNegative Net Change YELPNegative Net Change SABRPositive Net Change ATHMNegative Net Change
artificial-intelligence computers earnings saas tech-stocks
Tyler Technologies Gears Up to Report Q4 Earnings: What to Expect?
by Zacks Equity Research
TYL's Q4 performance is likely to have gained from robust demand for SaaS solutions as the public sector shifts from on-premise to cloud-based systems.
AKAMNegative Net Change SABRPositive Net Change ATHMNegative Net Change TYLNegative Net Change
artificial-intelligence computers earnings internet saas tech-stocks
Paycom Gears Up to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
Despite macroeconomic headwinds, strength in clientele, automation and international expansion are likely to aid PAYC's Q4 results.
AKAMNegative Net Change SABRPositive Net Change ATHMNegative Net Change PAYCNegative Net Change
artificial-intelligence computers earnings internet saas tech-stocks
Fortinet Q4 Earnings Surpass Expectations, Sales Increase Y/Y
by Zacks Equity Research
FTNT's fourth-quarter results reflect strength in demand from large enterprise customers and growth in the company's security subscriptions.
FTNTNegative Net Change ANETNegative Net Change FRSHNegative Net Change CANNegative Net Change
earnings saas tech-stocks
TAL Education (TAL) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
TALPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
World Acceptance (WRLD) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
WRLDNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Blueprint Medicines (BPMC) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
BPMCNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Pacira (PCRX) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
PCRXNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Is IBM Stock a Portfolio Must-Have Post Solid Q4 Earnings?
by Supriyo Bose
With solid fundamentals and healthy revenue-generating potential driven by robust demand trends, IBM appears to be a solid investment proposition.
AMZNNegative Net Change MSFTNegative Net Change IBMNegative Net Change
artificial-intelligence cloud-computing communications computers cybersecurity iot saas tech-stocks
Fortinet Gears Up to Report Q4 Earnings: What Should Investors Do?
by Vasundhara Sawalka
FTNT's Q4 2024 earnings are likely to have been aided by the steady growth of Security Fabric, cloud and SD-WAN offerings, making it worth buying for investors.
CSCONegative Net Change CHKPNegative Net Change FTNTNegative Net Change PANWNegative Net Change
saas tech-stocks
Snap to Report Q4 Earnings: What's in Store for the Stock?
by Zacks Equity Research
SNAP's Q4 results are likely to benefit from the growing adoption of the Snapchat platform, driven by new feature additions and AI integration efforts.
QCOMNegative Net Change PINegative Net Change LITENegative Net Change SNAPNegative Net Change
artificial-intelligence automation computers earnings internet saas tech-stocks
Grupo Aeroportuario del Centro Norte (OMAB)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
OMABNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
UiPath (PATH) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
PATHNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Vor Biopharma Inc. (VOR)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
VORNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines